For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

Date published: August 2011
Medicines should only be used short term for sleep problems. Learning good sleep habits can be just as effective and lasts longer.
If you and your doctor think that a medicine is necessary, prolonged-release melatonin is an alternative to other sleep medicines that can have unpleasant side effects. Between 30% and 50% of people will probably get some benefit from prolonged-release melatonin — either in the quality of sleep, or the time it takes to fall asleep. It does not seem to affect the overall length of time spent sleeping.
Prolonged-release melatonin tablets do not seem to affect daytime alertness or cause addiction or withdrawal symptoms.
Prolonged-release melatonin is approved for use for up to 3 months.
The active ingredient is the chemical in the medicine that makes the medicine work.
Many medicines are known by their brand names as well as by the name of the active ingredient. Some medicines are available under several different brand names.
The active ingredient of this medicine is melatonin (pronounced mel-ah-TOE-nin).
Melatonin is a chemical produced naturally by the body.
Circadin is the brand name for a synthetic melatonin in the form of prolonged-release tablets.
This Medicine Update is not about other forms of melatonin.
Sleep problems can be caused by:
In which case, the sleep problem is known as ‘secondary insomnia’.
Prolonged-release melatonin is used to treat primary insomnia.
Insomnia is a persistent sleep problem where people find it difficult to get to sleep or stay asleep, or they have poor quality sleep. This affects their ability to function properly the next day.
Primary insomnia is when this sleep problem is not caused by a medical condition, another medicine, use of illicit drugs, or external reasons such as a poor sleeping environment.
Studies into the effectiveness of prolonged-release melatonin demonstrated the best results in people 55 years of age or older. It was not found to be particularly effective for people younger than this.
An autoimmune disease is where the body is attacked by the immune system. Some examples include rheumatoid arthritis, multiple sclerosis, lupus and inflammatory bowel disease.
Talk with your health professional about all the treatment options for your insomnia.
See NPS resources with advice on how to get a good night’s sleep.
Prolonged-release melatonin is approved for treating primary insomnia in people who are over 55 years of age.
You will need a prescription from your doctor for prolonged-release melatonin. (See section 10 for information on the cost.)
Speak to your doctor before taking prolonged-release melatonin if you:
Prolonged-release melatonin is not approved for treating jet lag.
Prolonged-release melatonin is not suitable if you have secondary insomnia (see section 2).
No matter which type of insomnia you have, ask your health professional for advice about improving your sleep habits. This can be an effective way to solve sleep problems without taking medicines.
Take one prolonged-release melatonin tablet at around the same time each night — 1 to 2 hours before going to bed. Do not take it much earlier as this may cause problems with waking early.
Swallow the tablet whole with water. Don’t crush, chew or break the tablet.
It’s best to take the tablet soon after eating, as this will help with the prolonged-release effect for this form of melatonin.
You should avoid drinking alcohol before or after taking a tablet. Alcohol interferes with the absorption of melatonin so that it may be less effective.
Ask your doctor how long to take prolonged-release melatonin for. It is approved for up to a maximum of 3 months (13 weeks). There is no evidence that the benefits are maintained when you stop taking it.
A clinical trial is a research study conducted with patients, which compares one treatment with one or more other treatments, or with no other treatment, to assess its effectiveness and safety.
A dummy pill, or placebo, has no active ingredient. Participants in clinical trials do not know whether they are taking the active or dummy medicine.
To find out more about clinical trials, see What are clinical trials and why are they important?
The melatonin your body produces naturally usually increases as it is getting dark and continues to rise during the night. This helps to regulate the body’s sleep–wake cycle. It is thought that as we age, natural melatonin levels reduce and this may contribute to sleep problems.
Prolonged-release melatonin tablets provide your body with additional melatonin. This may improve your quality of sleep and morning alertness.
In clinical trials, prolonged-release melatonin helped improve some aspect of sleep (e.g. sleep quality, morning alertness) for between 30% and 50% of people. However, the same improvements were found in 20% to 30% of people taking a dummy pill (placebo).
The time it took to fall asleep was reduced by an average of 9 minutes. But there was no significant change in the length of time spent sleeping.
For a list of possible side effects, see the consumer medicine information (CMI) leaflet for Circadin (prolonged-release melatonin).
Common is one of the terms used to describe the chance of getting a side effect. It means that up to 1 in 10 people (10%) might get that side effect.
Always tell your doctor about any changes to your condition if you are taking a new medicine.
You can also discuss side effects with a pharmacist by calling the Adverse Medicines Event (AME) Line on 1300 134 237 (Mon–Fri, 9am–5pm).
All medicines can have side effects. Sometimes the side effects are serious, but most of the time they are not.
People reported several different side effects in clinical trials. The most frequently reported common side effects were:
Information on the side effects from taking melatonin for longer than 6 months is still limited.
Melatonin doesn’t seem to be addictive or cause withdrawal effects after stopping.
An interaction is when another medicine, food or drink (including alcohol) changes how strongly a medicine works, or changes its side effects in some way.
The interaction may be with a food or food supplement, another prescription or over-the-counter medicine, or a natural or herbal remedy.
The NPS Medicines Name Finder can help you identify your prescription medicines by the active ingredient name and brand name.
Use a medicine list to help keep track of the medicines you are taking. Take it with you each time you visit your health professional, or if you go into hospital.
Get an NPS Medicines List as a printed card or app for your iPhone.
Do not take melatonin with other medicines for sleep problems, including non-prescription or herbal remedies, as it may interact with them.
In particular, you should not take melatonin if you are taking the following medicines:
It may also interact with:
Check with your doctor or pharmacist before using these medicines together.
Prolonged-release melatonin rarely causes daytime drowsiness, but it is not recommended that you drive or operate machinery for 8 hours after you take it. If you do feel drowsy during the day, you should consult your doctor.
There are ways to improve your sleep without using medicines — see section 11 for more information. Your doctor can also help you find out about cognitive and behavioural therapies for the treatment of insomnia. These have been found to be just as effective as medicines and have a longer-lasting effect on sleep.
Most prescription sleep medicines are only suitable for short-term use due to the risk of side effects and addiction.
| Active ingredient | Brand names |
|---|---|
| Flunitrazepam | Hypnodorm |
| Nitrazepam | Alodorm, Mogadon |
| Temazepam | Normison, Temtabs, Temaze |
| Zolpidem | Dormizol, Somidem, Stildem, Stilnox, Zolpibell |
| Zopiclone | Imovane, Imrest |
Several complementary medicines — including chamomile, hops, lavender, passiflora and valerian — are used to treat insomnia. There is some evidence to suggest that valerian may be helpful (section 9), but less for the others.
People sometimes use medicines called sedating antihistamines to help them sleep. These are available over the counter at pharmacies.
But they are not suitable for treating insomnia, particularly in older people, because they quickly stop being effective. They can also cause unpleasant side effects such as dry mouth, constipation and blurred vision.
| Active ingredient | Some brand names |
|---|---|
| Diphenhydramine | Snuzaid, Unisom Sleepgels |
| Doxylamine | Dozile, Restavit |
| Promethazine | Phenergan |
Remember that benefits and side effects differ between medicines and from person to person.
For more information about zolpidem, see our NPS fact sheet.
Talk to your doctor or pharmacist about your insomnia. Remember, effective non-drug options are available and are probably more helpful than medicines in the long term.
You need to consider the side effects as well as the potential benefits when deciding to take a medicine for insomnia. No medicine should be taken for longer than the recommended period.
In clinical trials, between 30% and 50% of people who took prolonged-release melatonin felt their sleep had improved. But so did 20% to 30% of people who took a dummy pill (placebo).
The time taken to fall asleep, quality of sleep and morning alertness may improve, but not the total length of time spent sleeping.
The prescription sleep medicines listed in section 8 — like nitrazepam and zolpidem — are generally effective. But they can disturb the normal rhythm of sleep so it may not be as deep or restful.
They should only be used for a short time. If you take them for longer than 4 weeks, it can be difficult to stop. And when you do stop, you may get withdrawal symptoms — including muscle pain, tremors, anxiety and depression — or your insomnia might be worse than it was before (rebound insomnia).
There is currently no evidence to suggest that prolonged-release melatonin causes dependence or withdrawal effects.
Prolonged-release melatonin doesn’t seem to cause problems with drowsiness or concentration during the day for most people.
But other sleep medicines can. Problems include drowsiness, poor concentration, memory loss and dizziness. These can increase the risk of a fall or a car accident.
Zolpidem and zopiclone (see section 8) have been linked to uncommon — but potentially dangerous — side effects like sleepwalking, sleep-eating and sleep-driving.
There is currently no evidence to suggest that other prescription sleep medicines or prolonged-release melatonin cause similar effects.
Some studies suggest that valerian can reduce the time it takes to fall asleep and improve the quality of sleep. But the studies only lasted for about 6 weeks, so they did not provide information about longer term use.
When a medicine prescribed by your doctor is not covered by the Pharmaceutical Benefits Scheme (PBS), you will need to pay the full price.
See our MedicinesTalk article to find out more about private prescriptions.
Prolonged-release melatonin is not covered by the Pharmaceutical Benefits Scheme (PBS). It is only available by private prescription.
The price may vary between different pharmacies, but as an indication you should expect to pay around $30.00 for 3 weeks’ supply of prolonged-release melatonin tablets.
Developing good sleep habits is more effective than using medicines. In the long term, most sleep medicines usually make sleep problems worse, not better.
If you’re having problems sleeping, these tips will get you on the right track:
The following resources with advice on how to get a good night’s sleep are available:
The CMI for Circadin (prolonged-release melatonin) will tell you:
NPS works with healthdirect Australia to provide consumers with information on medicines.
To get information about prolonged-release melatonin, call 1300 MEDICINE (1300 633 424) from anywhere in Australia for the cost of a local call (excluding mobiles). This service is available Monday to Friday, 9am–5pm EST, with the exception of NSW public holidays.
Call the Adverse Medicine Events (AME) Line on 1300 134 237 (Monday to Friday, 9am–5pm EST).
The AME Line lets you report and discuss side effects that might be related to your medicine. The side effects of your medicine — but not your personal details — are reported to the Australian medicines regulatory agency, the Therapeutic Goods Administration (TGA). The information helps to improve the safe use of medicines.
The Australian Self Medication Industry (ASMI) provides more information on understanding side effects.
Date published: 2011-08-05 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.